Skip to main content

Advertisement

Table 2 Operative and postoperative characteristics

From: Safety and feasibility of contained uterine morcellation in women undergoing laparoscopic hysterectomy

Perioperative characteristics Leiomyoma (N = 35) Uterine cancer (N = 53)
Robotic platform 26 (74.3) 34 (64.2)
Uterine weight (grams)a 448.35 ± 194.9 [range 140–1076] 321.77 ± 102.1 [range 135–611]
Intra-op size estimate (weeks)b 14.8 ± 2.6 [range 10–20] 12.5 ± 2.2 [range 6–16]
Operative time (minutes)c 206.0 ± 76.3 [range 115–391] 237.5 ± 67.0 [range 131–399]
Abdominal/pelvic Adhesions 13 (37.1) 35 (34.0)
Length of stayd 0.97 ± 0.5 [range 0–3] 1.12 ± 0.4 [range 0–3]
Mode of morcellation
 Port site 3 (8.6) 0 (0)
 Vaginal 29 (82.9) 52 (98.1)
 Other 3 (8.6) 1 (1.9)
Post-op Diagnosis
 Leiomyoma 35 (100) 40 (75.5)
 Endometrial cancere 1 (2.9) 53 (100)
 Benign ovarian neoplasm 9 (25.7) 6 (11.3)
 Adenomyosis 13 (37.1) 18 (33.9)
 Pelvic adhesive disease 8 (22.9) 9 (17.0)
 Otherf 18 (51.4) 12 (22.6)
Post-op complicationsg 3 (8.6) 4 (7.5)
Length of follow-up (months) 31 ± 21 [range 3–89] 24 ± 21 [range 1–85]
  1. Data are n (%) or mean ± SD unless otherwise specified
  2. aMissing data: n = 34 for leiomyoma group, n = 52 for uterine cancer group
  3. bMissing data: n = 30 for leiomyoma group, n = 24 for uterine cancer group
  4. cMissing data: n = 33 for leiomyoma group, n = 52 for uterine cancer group
  5. dMissing data: n = 52 for uterine cancer group
  6. eIncidental finding of Stage IA, grade 1 endometrioid adenocarcinoma, no adjuvant therapy
  7. fIncludes endometrial intraepithelial neoplasia (3), abnormal uterine bleeding (4), family history of cancer (1), terminal ileum cancer (1), anemia (1), breast cancer (1), pelvic pain (1), abdominal wall mesothelioma (1), retroperitoneal fibrosis (2), urethral diverticulum (1) ovarian cancer (1), endometrial polyp (3), endometriosis (3)and history of rectovaginal fistula repair (1) in the leiomyoma group and hydrosalpinx (1), endometriosis (1), ventral hernia (1) and appendicitis (1) for the endometrial cancer group
  8. gIncludes readmission for grade (G) 1 vaginal cuff separation after intercourse, as well as G1 port-site hematoma (1), G2 port-site cellulitis (1), G2 vaginal cuff cellulitis (2), G2 bladder infection (2), G2 pulmonary edema (1), and G1 musculoskeletal injury (1)